Showing results (41-50 of 83) with videos related to
Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
A randomized phase II study comparing sequential versus simultaneous chemo-radiotherapy in patients with unresectable locally advanced squamous cell cancer of the head and neckP Pinnarò, M C Cercato, D Giannarelli, et al.Cancer|September 15, 1987
Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neckM Clavel, F Cognetti, P Dodion, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2011
Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trialF Cognetti, E M Ruggeri, A Felici, et al.Journal of Experimental & Clinical Cancer Research : CR|November 8, 2005
Choroid plexus carcinoma in the adult: is there a role for chemotherapy?A Fabi, N Salesi, B Di Cocco, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): is a clinical benefit still achievable?P Carlini, A Frassoldati, S De Marco, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Randomised phase II study of methotrexate (MTX) versus methotrexate plus lonidamine (MTX + LND) in recurrent and/or metastatic carcinoma of the head and neckE Colella, M Merlano, F Blengio, et al.European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy. European Dolasetron Comparative Study GroupA A Fauser, B Duclos, A Chemaissani, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysisE Bria, M Milella, F Cuppone, et al.British Journal of Cancer|November 27, 1999
Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non-small-cell lung cancer: a phase II studyA F Scinto, V Ferraresi, M Milella, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2010
Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabineG Metro, J Foglietta, M Russillo, et al.Pageof 9